You can buy or sell APEN and other stocks, options, ETFs, and crypto commission-free!
Apollo Endosurgery, Inc. Common Stock, also called Apollo Endosurgery, is a medical technology company, which engages in the design, development, and commercialization of medical devices. Read More It offers medical devices for bariatric and gastrointestinal procedures under the ORBERA and OverStitch brands. The company was founded by Christopher J. Gostout in 2006 and is headquartered in Austin, TX.
52 Week High
52 Week Low
Seeking AlphaMar 18
Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q4 2018 Results - Earnings Call Transcript
Apollo Endosurgery, Inc. (NASDAQ:APEN) Q4 2018 Earnings Conference Call March 18, 2019 8:30 AM ET Company Participants John Gillings - Investor Relations Todd Newton - Chief Executive Officer Stefanie Cavanaugh - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig Hallum JP McKim - Piper Jaffray Suraj Kalia - Northland Securities Operator Good morning, my name is Sharon, and I will be your conference operator today. At this time, I would like to welcome everyone to the Apollo ...
Stock Price, News, & Analysis for Apollo Endosurgery
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. It develops and distributes devices for minimally invasive surgical and non-surgical bariatric and gastrointestinal procedures that are used by surgeons and gastroenterologists in various settings to provide interventional therapy to patients who suffer from obesity and various co-morbidities associated with obesity, as well as treat various other gastrointestinal conditions....
-$0.37 per share
-$0.48 per share